Surgery

Cost Comparison: Laser vs. Eye Drops vs. Surgery in the U.S. Choosing the right glaucoma treatment isn’t just a medical decision — it’s also a financial commitment. The cost of treating glaucoma can vary dramatically depending on whether you use eye drops, undergo laser treatment, or opt for surgery. Since glaucoma is a lifelong condition,

Canaloplasty Surgery in the U.S. Canaloplasty surgery is a modern, minimally invasive glaucoma procedure that restores the eye’s natural drainage system. By opening and dilating Schlemm’s canal, this surgery improves fluid outflow, lowers intraocular pressure (IOP), and helps prevent vision loss without creating a bleb (a fluid pocket under the conjunctiva). Because it avoids full-thickness

Viscocanalostomy Surgery in the U.S. Viscocanalostomy is an advanced non-penetrating glaucoma surgery designed to lower intraocular pressure (IOP) while reducing the risks associated with traditional filtering surgeries. The procedure enhances the eye’s natural drainage system, allowing fluid (aqueous humor) to flow more freely and protect the optic nerve from further damage. This technique is particularly

Deep Sclerectomy Surgery in the U.S. Deep Sclerectomy is a highly effective, non-penetrating glaucoma surgery designed to lower intraocular pressure (IOP) while minimizing complications. By creating a new drainage pathway in the outer layers of the eye (sclera), this procedure allows fluid (aqueous humor) to flow out more efficiently, preventing optic nerve damage and preserving

Laser Cyclophotocoagulation (CPC) in the U.S. Laser Cyclophotocoagulation (CPC) is a highly effective treatment used to lower eye pressure in patients with moderate to advanced glaucoma. This procedure targets the ciliary body, the part of the eye that produces fluid, reducing intraocular pressure and helping protect the optic nerve from further damage. Why CPC Is

Minimally Invasive Glaucoma Surgery (MIGS) Cost in the U.S. (2025) Minimally Invasive Glaucoma Surgery (MIGS) has become one of the most preferred options for patients with mild to moderate glaucoma. It is designed to lower intraocular pressure (IOP) with less trauma compared to traditional procedures like trabeculectomy. In 2025, many patients in the United States